tirzepatide and epilepsy ๐ง Let's break the drug down using this mnemonic cloud!โ โ ๐ Tirzepatide is a GLP-1 GIP agonist. โ โ ๐คBut what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? โ โ New Tirzepatide Access and Pricing
Description
Smaller pack sizes are a key way the food industry is reacting to GLP-1 drugs, and smaller drinks sizes could follow this trend: if consumers arent feeling hugely hungry or thirsty, smaller pack sizes can them to reach hydration goals by drinking little and often
#Xtrategical #Biosimilar #FDA #EMA #RegulatoryAffairs #MarketAccess #HealthReform #HealthforAll To view or add a comment, sign in 4,165 followers More from this author This week's biggest news and stories in the pharmaceutical industry 17/07/2026 Pharmaceutical-Technology 1d This week's biggest news and stories in the pharmaceutical industry 10/07/2026 Pharmaceutical-Technology 1w This week's biggest news and stories in the pharmaceutical industry 03/07/2026 Pharmaceutical-Technology 2w
Important factors include: A1C level current diabetes medications hypoglycemia risk cardiovascular history kidney function weight goals side effect history insurance coverage contraindications Do not choose based only on online weight-loss comparisons
"Public health and safety concerns have emerged around the complexity and commercial scale of some compounding of extemporaneously prepared GLP-1 RAs, which are sterile medicines containing high-risk active substances," the TGA said in a statement
1.0 mg/d) on HF events
It was found to be more efficacious than placebo [1.33(1.55, 1.12)]
